SANOFI VENTURES
Sanofi Ventures is the corporate venture capital arm of Sanofi. We have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic interest to Sanofi. Among these areas are rare diseases, oncology, immunology and inflammation, vaccines, potential cures in other core areas of Sanofi’s business footprint, and digital health and data science solutions.
SANOFI VENTURES
Industry:
Biotechnology Financial Services Health Care
Founded:
1994-01-01
Status:
Active
Technology used in webpage:
Amazon
Similar Organizations
Saint-Gobain NOVA
Saint-Gobain NOVA is the ventures arm of Saint‑Gobain.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-29 | ReCode Therapeutics | Sanofi Ventures investment in Series B - ReCode Therapeutics | 120 M USD |
| 2022-04-27 | OMass Technologies | Sanofi Ventures investment in Series B - OMass Technologies | 75.5 M GBP |
| 2022-03-22 | Nucleai | Sanofi Ventures investment in Series B - Nucleai | 33 M USD |
| 2021-10-22 | Click Therapeutics | Sanofi Ventures investment in Series B - Click Therapeutics | 52 M USD |
| 2021-10-21 | ReCode Therapeutics | Sanofi Ventures investment in Series B - ReCode Therapeutics | 80 M USD |
| 2021-09-29 | Expansion Therapeutics | Sanofi Ventures investment in Series B - Expansion Therapeutics | 80 M USD |
| 2021-09-14 | ROME Therapeutics | Sanofi Ventures investment in Series B - ROME Therapeutics | 77 M USD |
| 2021-07-09 | Muna Therapeutics | Sanofi Ventures investment in Series A - Muna Therapeutics | 73 M USD |
| 2021-06-23 | Glycomine | Sanofi Ventures investment in Series B - Glycomine | 35 M USD |
| 2021-06-16 | Veralox Therapeutics | Sanofi Ventures investment in Series A - Veralox Therapeutics | 16.6 M USD |
More informations about "Sanofi Ventures"
Our Approach - Sanofi Ventures
Our raison d' ê tre. We invest in the innovators behind the miracles of science who are passionate about improving human health. Sanofi Ventures serves as an entry point to the innovation ecosystem for Sanofi, strategically investing … See details»
Sanofi Ventures - The Org
Sanofi Ventures is the corporate venture capital arm of Sanofi. They have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products … See details»
Strategic Partnerships l Sanofi
Sanofi's pioneering healthcare effort through strategic partnerships, venture capital investment, and alliance management. Join us in advancing patient care. ... Sanofi Ventures invests in early-stage … See details»
Sanofi Ventures Org Chart + Executive Team - The Official Board
The org chart of Sanofi Ventures contains its 8 main executives like Jason Hafler, Laia Crespo and Paulina Hill. See details»
Sanofi Ventures - Crunchbase Investor Profile
Sanofi Ventures is the corporate venture capital arm of Sanofi. We have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic … See details»
Sanofi Ventures - Investment Management Team - The Org
The Investment Management Team at Sanofi Ventures is responsible for identifying, evaluating, and managing investment opportunities in innovative early-stage companies. They focus on sectors … See details»
Sanofi Ventures - Private Equity List
Sanofi Ventures. Investor type. CVC. Founded. 2004. AUM-Location. United States. $1-5 m. Investment Ticket. 3-5 years. ... Our venture model serves as an "innovation front door" to Sanofi. … See details»
List of top Sanofi Ventures Portfolio Companies - Crunchbase
Jun 1, 2014 Sanofi Ventures operates as the corporate venture capital arm of Sanofi. This list of organizations invested in by Sanofi Ventures provides data on their funding history, investment … See details»
Sanofi Ventures - Investments, Portfolio & Company Exits
Sanofi Ventures 's most notable exits include Inozyme, Kymera Therapeutics, and Q32 Bio. Unlock for free . Investments. Edit Investments Section. Number of Portfolio Organizations 67. Number of … See details»
Our Team - Sanofi Ventures
Cris joined Sanofi Ventures in 2020 as a Partner to lead investments in Digital Health and Artificial Intelligence. He has a 20-year track record of building startups, tech innovation platforms, and healthtech deal making with some of … See details»
Evergreen Sanofi Ventures increases to $750M with further Sanofi ...
5 days ago Sanofi Ventures – focused on early-to-mid stage investing, company co-creation, leading financing rounds, and prioritising those companies advancing innovation – has … See details»
News - Sanofi Ventures
About Sanofi Ventures. Sanofi Ventures is the corporate venture capital arm of Sanofi, focused on investing in promising early-stage healthcare companies. The firm supports pioneering … See details»
Press Release: Sanofi Ventures announces multi-year capital …
Jan 11, 2016 Sanofi Ventures invests in top innovators working in areas including immunology and inflammation, rare diseases, oncology, cell and gene therapy, vaccines, and digital health and … See details»
Sanofi to bolster its VC unit with $750M commitment
Jan 12, 2023 Sanofi Ventures has been ramping up its investments over the past few years. In 2022, the firm made its second-highest number of deals, backing 10 rounds worth a total of … See details»
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare ...
2 hours ago PARIS and CAMBRIDGE, Mass., June 2, 2025 /PRNewswire/ -- Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company … See details»
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a …
May 21, 2023 Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Paris, May 22, 2025. ... By strategically … See details»
Portfolio - Sanofi Ventures
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulator agencies. Founded by Harvard Medical School faculty members … See details»
Corporate Venturing - Harvard Business Review
Reprint: R1310D For decades, large companies have been wary of corporate venturing. But as R&D organizations face pressure to rein in costs and produce results, companies are investing in ... See details»
About us | VANQUISH VENTURES LLC.
Under his leadership, PROCOMER was acclaimed as the "Best Trade andInvestment Promotion Organization in the World" for eight consecutive years (2015-2023). ... “The world is ready for … See details»
Geoff Beattie - CEO @ Generation Capital - Crunchbase
Geoff is Chairman of Relay Ventures, an early stage venture fund exclusively focused on mobile computing. He received a law degree from the University of Western Ontario and served as a … See details»